Overview

  • Product nameAnti-MAP2a + MAP2b antibody [AP20] (FITC)
    See all MAP2a + MAP2b primary antibodies
  • Description
    Mouse monoclonal [AP20] to MAP2a + MAP2b (FITC)
  • ConjugationFITC. Ex: 493nm, Em: 528nm
  • Specificityab24279 reacts with the high molecular weight forms (2a & 2b) of MAP-2 but not with the low molecular weight form (2c). It reacts with dendrites and cell bodies of neurons.
  • Tested applicationsSuitable for: IHC-Fr, WBmore details
  • Species reactivity
    Reacts with: Mouse, Rat, Chicken, Human
  • Immunogen

    The details of the immunogen for this antibody are not available.

Properties

Applications

Our Abpromise guarantee covers the use of ab24279 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IHC-Fr
WB
  • Application notesIHC-Fr: 1/500. WB: Use at an assay dependent dilution. Detects a band of approximately 300 kDa. Dilution optimised using Chromogenic detection. Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.
  • Target

    References for Anti-MAP2a + MAP2b antibody [AP20] (FITC) (ab24279)

    This product has been referenced in:
    • Schober et al. Microfluidics and biosensors as tools for NanoBioSystems research with applications in the "Life Science" Materials Science and Engineering: B 169:174-181 (2009). ICC/IF ; Mouse . Read more (PubMed: ) »
    • Guzman R  et al. Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Proc Natl Acad Sci U S A 104:10211-6 (2007). Read more (PubMed: 17553967) »

    See all 3 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab24279.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"